Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kelly F Bell

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
The American Journal of Managed Care|April 16, 2019
Authors' reply to "Comment on generalizability of GLP-1 RA CVOTs in US T2D population"Eric T Wittbrodt, James M Eudicone, Kelly F Bell, et al.
The American Journal of Managed Care|April 26, 2018
Generalizability of glucagon-like peptide-1 receptor agonist cardiovascular outcome trials enrollment criteria to the US type 2 diabetes populationEric T Wittbrodt, James M Eudicone, Kelly F Bell, et al.
The American Journal of Managed Care|April 26, 2018
A retrospective real-world study of dapagliflozin versus other oral antidiabetic drugs added to metformin in patients with type 2 diabetesHuan Huang, Kelly F Bell, Ray Gani, et al.
Future Oncology (London, England)|August 2, 2023
Metastatic non-small-cell lung cancer without driver mutations: projections by therapy line in Western Europe, 2021-2026Xinmei Zhu, Laura Durbin, Gena Kanas, et al.
Advances in Therapy|August 29, 2025
Patient and Physician Preferences for Maintenance Treatment in Advanced Non-Small Cell Lung Cancer: Insights into Treatment SelectionManasee V Shah, Caitlyn T Solem, Anne Liao, et al.
Advances in Therapy|April 15, 2025
Real-World Maintenance Treatment Patterns Among Patients with Advanced Non-Small Cell Lung CancerManasee V Shah, Caitlyn T Solem, Kelly F Bell, et al.
Thoracic Cancer|August 18, 2023
Real-world treatment patterns and clinical outcomes after introduction of immune checkpoint inhibitors: Results from a retrospective chart review of patients with advanced/metastatic non-small cell lung cancer in the EU5Alexander Slowley, Kelesitse Phiri, Jasjit K Multani, et al.
Cancer Investigation|June 5, 2023
The Utility of ctDNA in Lung Cancer Clinical Research and Practice: A Systematic Review and Meta-Analysis of Clinical StudiesXuezheng Sun, Page Abrahamson, Nicholas Ballew, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
The American Journal of Managed Care|April 16, 2019
Authors' reply to "Comment on generalizability of GLP-1 RA CVOTs in US T2D population"Eric T Wittbrodt, James M Eudicone, Kelly F Bell, et al.
The American Journal of Managed Care|April 26, 2018
Generalizability of glucagon-like peptide-1 receptor agonist cardiovascular outcome trials enrollment criteria to the US type 2 diabetes populationEric T Wittbrodt, James M Eudicone, Kelly F Bell, et al.
The American Journal of Managed Care|April 26, 2018
A retrospective real-world study of dapagliflozin versus other oral antidiabetic drugs added to metformin in patients with type 2 diabetesHuan Huang, Kelly F Bell, Ray Gani, et al.
Future Oncology (London, England)|August 2, 2023
Metastatic non-small-cell lung cancer without driver mutations: projections by therapy line in Western Europe, 2021-2026Xinmei Zhu, Laura Durbin, Gena Kanas, et al.
Advances in Therapy|August 29, 2025
Patient and Physician Preferences for Maintenance Treatment in Advanced Non-Small Cell Lung Cancer: Insights into Treatment SelectionManasee V Shah, Caitlyn T Solem, Anne Liao, et al.
Advances in Therapy|April 15, 2025
Real-World Maintenance Treatment Patterns Among Patients with Advanced Non-Small Cell Lung CancerManasee V Shah, Caitlyn T Solem, Kelly F Bell, et al.
Thoracic Cancer|August 18, 2023
Real-world treatment patterns and clinical outcomes after introduction of immune checkpoint inhibitors: Results from a retrospective chart review of patients with advanced/metastatic non-small cell lung cancer in the EU5Alexander Slowley, Kelesitse Phiri, Jasjit K Multani, et al.
Cancer Investigation|June 5, 2023
The Utility of ctDNA in Lung Cancer Clinical Research and Practice: A Systematic Review and Meta-Analysis of Clinical StudiesXuezheng Sun, Page Abrahamson, Nicholas Ballew, et al.
Pageof 2